share_log

多瑞医药(301075.SZ):2023年度净利润1885.07万元 拟10派1.25元

Dorui Pharmaceuticals (301075.SZ): 2023 net profit of 18.857,700 yuan, plans to distribute 10 to 1.25 yuan

Gelonghui Finance ·  Apr 17 08:56

On April 17, Ge Longhui Pharmaceutical (301075.SZ) announced its 2023 annual report. In 2023, the company achieved operating income of 334 million yuan, a year-on-year decrease of 16.64%; net profit attributable to shareholders of listed companies was 18.8507 million yuan, a year-on-year decrease of 8.05%; net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses was 5.258 million yuan, a year-on-year decrease of 34.96%; basic earnings per share of 0.24 yuan; it plans to distribute a cash dividend of 1.25 yuan (tax included) for every 10 shares to all shareholders.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment